Hotgen’s Up-Converting Phosphor Technology (UPT) testing products is a new generation of fluorescence detection platform. Applying unique UPT technology, the platform is maintains the short incubation time of fluorescence diagnostics, while significantly improving precision measurement such as signal/noise ratio and enhancing the stability of testing results.

 

UPT2800 analyzer is the latest version of UPT machine, which is marked by compact size, easy operations and maintenance, and versatile application scenarios. The device is widely accepted by various medical institutions, as well as food-related industries and government branches.

 

Specification of Up-Converting Phosphor Technology (UPT) Analyzer

Assay Method	Up–converting phosphor technology–based lateral flow assay
Result	Quantitative
Language	English/German/Chinese
Display	8 inch touch screen
Detection speed	Getting results in 20 seconds.
Printer	Internal thermal printer
Storage memory	10,000 test results
Power supply	AC 100–240V，50 ～ 60Hz
Working environment	Temperature: 10℃~30 ℃; Humidity: ≤85%; Atmospheric pressure: 86 kpa ～ 106kpa
Transportation and storage environment	Temperature: –40 ℃~+ 55 ℃; Humidity: ≤85%; Atmospheric pressure: 86 kpa ～ 106 kpa
Dimension	355mm×315mm×270mm（ (L×W×H)
Weight	5.6kg
Data management	Lls/HlS connection

 

What are the Storage Requirements for Up-Converting Phosphor Technology (UPT) Analyzer

Transportation and storage environment:

 

Temprature:-40℃~+50℃

 

Humidity:≤85%

 

Atmospheric pressure:86kPa~106kPa

 

What Types of Disease Can Hotgen’s Up-Converting Phosphor Technology (UPT) Analyzer Test？

Using along with Hotgen’s Up-converting Phosphor Technology (UPT) testing reagents, UPT device can detect a variety of biological markers. These markers include medical markers for cardiac diseases, inflammation, rheumatoid arthritis, and other diseases, and industrial markers such as mycotoxins.

 

 

Hotgen provides a broad portfolio of invitro diagnostics for laboratories, medical institutions and diagnostic partners. The portfolio includes chemiluminescence immunoassay products, Up-Converting Phosphor Technology products, colloidal gold rapid test kits, ELISA kits, IVD raw materials.

 

With more than 130 testing parameters across multiple platforms, Hotgen’s ivd business products cover applications including cardiac biomarkers, inflammation, tumor markers, thyroid function, infectious diseases and other diagnostic areas. Customers can compare products according to testing method, intended application, compatible sample type, laboratory workflow and applicable regulatory requirements.

 

Types of Hotgen IVD Diagnostic Products

 

Chemiluminescence Immunoassay (CLIA) Products

 

Mono-test CLIA MQ60 series

 

Automatic CLIA C2100

 

Chemiluminescence Immunoassay Kit

 

Chemiluminescence Immunoassay (CLIA) Products

 

Hotgen's CLIA portfolio includes mono-test and automatic chemiluminescence immunoassay analyzers, together with compatible reagent kits. Different analyzer options are available to support varying laboratory workloads, levels of automation and test-menu requirements.

 

Up-Converting Phosphor Technology (UPT) Products

 

Up-Converting Phosphor Technology (UPT) Analyzer

 

Up-Converting Phosphor Technology Test Kit

 

Up-Converting Phosphor Technology (UPT) Products

 

Hotgen’s UPT portfolio includes fluorescence-based analyzers and test kits for multiple diagnostic applications. The platform provides an additional testing option for medical institutions requiring flexible instrument and reagent combinations.

 

Colloidal Gold (CG) Immunoassay/Rapid Test Kit

 

Cardiac Rapid Test Kit

 

Inflammation Rapid Test Kit

 

Rheumatoid Arthritis Rapid Test Kit

 

Infectious Disease Rapid Test Kit

 

Preterm Birth Prediction Rapid Test Kit

 

Covid-19 Self testing Kit

 

Mpox（monkeypox） Virus Rapid Test Kits

 

Dengue Fever Rapid Test Kits

 

Colloidal Gold (CG) Immunoassay/Rapid Test Kit

 

As one of ivd manufacturers, Hotgen offers colloidal gold rapid test kits for cardiac markers, inflammation, rheumatoid arthritis, infectious diseases, preterm birth prediction and other testing applications. The portfolio is designed for testing scenarios that require a straightforward procedure and timely results.

 

Enzyme-linked Immunosorbent Assay (ELISA) Kit

 

Tumor Marker Assay (ELISA) Kit

 

Liver Disease Assay (ELISA) Kit

 

Rheumatoid Arthritis Assay (ELISA) Kit

 

Cardiovascular Assay (ELISA) Kit

 

Enzyme-linked Immunosorbent Assay (ELISA) Kit

 

Hotgen’s ELISA portfolio includes assay kits for tumor markers, liver diseases, rheumatoid arthritis and cardiovascular applications. These products support laboratories that use established microplate-based immunoassay workflows.

 

IVD & Drug Raw Material

 

IVD Raw Material

 

Drug Raw Material

 

IVD & Drug Raw Material

 

As a vitro diagnostics inc, Hotgen provides antigen and antibody raw materials for IVD reagent development, together with selected drug raw materials. The portfolio supports diagnostic and pharmaceutical partners with different research, development and manufacturing requirements.

 

Advantages of Hotgen IVD Diagnostic Products

 

Advanced-technology diagnostic platforms with precision and versatility

 

Trusted quality with 18,000+ installations

 

Comprehensive test catalogue of 130+parameters

 

All-scenario solutions for primary to high-end medical markets

 

Application Scenarios of Hotgen IVD Diagnostic Products

 

Application Scenarios of Hotgen IVD Diagnostic Products

 

Hotgen in vitro diagnostic ivd products support testing workflows across central laboratories, medical institutions, decentralized testing settings and, for specifically authorized products, home-testing environments. The appropriate product depends on its intended use, compatible sample type, testing volume, turnaround-time requirements and local regulatory status.

 

The portfolio supports automated chemiluminescence immunoassay testing, fluorescence-based detection, rapid testing, microplate-based assays and diagnostic reagent development. Customers should review the applicable instructions for use and market-specific product documentation before purchase or use.

 

 

The indications of IGRA mainly include the diagnosis of latent tuberculosis infection and the auxiliary diagnosis of active tuberculosis.

 

Interpretation of IGRA test results:

 

(1)A positive result supports the determination of the Mycobacterium tuberculosis infection status.

 

(2)A negative result does not support the determination of the infection status.

 

(3)An indeterminate result is one of the application limitations of this test.

 

Detection equipment

Analyzer Type	Fully automated Bench-top CLIA  Analyzer (MQ60 smart)
Sample type	Human serum, plasma, whole blood, urine, cerebrospinal luid
Host size	300mm x 565mm x 610mm (length×width×height)
Host weight	36.0kg
Languages	English
Mode	Batch mode
Channel	6 channels
Throughput	24 tests/hour
Storage	Result storage >1 million
Standby	24 hours operation standby
Data management	LIS/HIS connection

 

Now price of mtb tuberculosis test kits is reasonable. If you want to buy a tuberculosis rapid test kit, please contact us.

 

If you want to know more methods of diagnostic tests for pulmonary tuberculosis, please visit our website.

 

Rapid diagnosis of tuberculosis is possible with our high-quality, easy-to-use tuberculosis test kits, which deliver reliable results in a short testing period and meet the needs of on-site screening and primary medical institutions. Our products strictly follow international quality control standards for in vitro diagnostic reagents, with stable performance and high detection accuracy, supporting flexible purchase in various batch sizes to suit different usage scenarios.

 

 

 

 

 

With the continuous advancement of medical technology, the field of in vitro diagnostics (IVD) has also ushered in new revolutionary breakthroughs. The small molecule double antibody sandwich method, as an innovative detection technology, is gradually replacing traditional competitive methods and playing an increasingly important role in various detection projects. Hotgen, as an industry leader, has upgraded its thyroid function, hormones, vitamins, and other detection projects to the small molecule double antibody sandwich method and plans to launch more innovative products based on this technology in the future. This initiative not only enhances the precision and sensitivity of the detection but also provides more efficient and economical solutions for a wide range of medical institutions and patients.

 

Advantages of the Small Molecule Dual Antibody Sandwich Assay Method

 

Compared with the traditional competitive method, the small molecule double antibody sandwich assay method has many significant advantages. First, it can provide higher detection sensitivity, making the detection of low-concentration samples more accurate and reliable. Second, the sandwich method has a wider linear range, which means that it can detect target molecules over a broader concentration range, thereby improving the adaptability of the detection. Additionally, the sandwich method can offer better specificity, reducing the interference of cross-reactions and ensuring the accuracy of the detection results. With these advantages, the small molecule double antibody sandwich method is playing an increasingly important role in detecting various hormones, vitamins, cardiac, and cancer markers.

 

Hotgen's innovations in this field have already yielded noticeable results. Hotgen's thyroid function, hormones, vitamins, and other detection projects have successfully been upgraded to the small molecule sandwich assay method, with more projects set to upgrade based on this technology in the future. We are committed to providing the medical industry with more efficient and accurate diagnostic tools to meet clinical and patient needs through technological innovation.

 

Compliance with New EU Regulations: Hotgen Obtains International Certification

 

With the introduction of the new in vitro diagnostic (IVD) regulation — (EU) 2017/746 (IVDR) by the European Union, certification and regulatory standards for in vitro diagnostics products have become more stringent. According to this regulation, all in vitro diagnostic medical devices must meet stricter safety, quality, and efficacy requirements. Starting from May 26, 2022, the IVDR will be fully applicable across the European Union.

 

Hotgen greatly emphasizes product safety and quality, has obtained certification in compliance with the IVDR, and has successfully certified 93 new products, including cardiac, hormone, inflammation, and cancer markers. This not only signifies Hotgen's firm commitment to the quality and safety of diagnostic products but also demonstrates our profound attention and commitment to the needs of healthcare professionals and patients. By obtaining IVDR certification, Hotgen's products are qualified to enter the EU market, laying the foundation for providing high-quality diagnostic products to global users.

 

Leading Future Development with the Small Molecule Double Antibody Sandwich Method

 

Hotgen's sandwich immunoassay for small molecules method has achieved its first CE IVDR certification for single-detection chemiluminescence immunoassay (CLIA ) and up-converting phosphor technology (UPT). This certification marks another milestone for Hotgen in promoting high-precision immunodiagnostics in the international market. With innovative technology, Hotgen has not only achieved accuracy and cost-effectiveness in small molecule diagnostics such as vitamins and hormones but has also propelled more efficient diagnostic products to the global market.

 

In the future, Hotgen will continue to innovate in the field of the small molecule double antibody sandwich method, further expanding our product line to cover more detection projects. We always adhere to the principles of precision, economy, and flexibility, dedicated to providing high-quality diagnostic products for global medical institutions. Our products have been recognized and used by more than 10,000 medical institutions worldwide. Hotgen will continue to strengthen research and development to provide more innovative in vitro diagnostic products to meet the ongoing needs of the global market.

 

Hotgen's Global Vision

 

As an important player in the global in vitro diagnostics industry, Hotgen has always been at the forefront of precision diagnostic technology. Through continuous technological innovation and product optimization, Hotgen has obtained registrations and certifications in multiple countries and regions worldwide. We are confident that in the near future, more Hotgen diagnostic kits will be registered and recognized in the EU and globally. We will continue to promote the widespread application of the small molecule double antibody sandwich immunoassay method and other innovative technologies in the global medical diagnostics field, safeguarding the health of patients worldwide.

 

If you want to know more about sandwich chemiluminescent immuno assay and two site sandwich immunoassay, please visit our website.

Onnittelut uudesta blogistasi!

Tämä on esimerkkiartikkeli. Uutta sisältöä voit luoda blogin hallinnan kautta. Voit poistaa tämän artikkelin artikkeliarkiston kautta.